News | January 21, 2022
Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22
Biocon has reported consolidated financial results for the period ended December 31, 2021
Biocon has reported consolidated financial results for the period ended December 31, 2021
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
A CRISIL study of 207 pharmaceutical companies that account for 55% of the Rs 3.2 lakh crore-a-year sector revenue indicates as much.
Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 3rd December 2021 for a start of procedure in 2021
The rates for over 400 procedures were revised
These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products
The company said in a regulatory filing that it was confident of addressing the observations satisfactorily
This procedure is incidentally the first robotic bariatric surgery in the world to be performed in just three ports
This is Omeza’s first Rx product and the first drug/device combination matrix of its kind for chronic wound care
Subscribe To Our Newsletter & Stay Updated
